Anavex Life Sciences Submits Nasdaq Compliance Plan for Late 10-Q Filing

Anavex Life Sciences Corp. (AVXL) submitted a Compliance Plan to the Nasdaq Stock Market's Listing Qualifications Department to address its non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports. The company had previously received a deficiency notification for not timely filing its Form 10-Q for the quarter ended March 31, 2026.